Total debt of $133.0B against $43.5B of equity yields a debt-to-equity ratio of 2.78, suggesting a heavy capital structure relative to a 2.3% operating margin.
Jbs N.V. (JBS) balance sheet — 12-year assets, liabilities & shareholders' equity history
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 |
|---|
| Total Current Assets | 97.39B | 101.4B | 106.02B | 78.6B | 79.39B | 83.91B | 60.54B | 41.92B | 36.9B | 36.11B | 33.92B | 49.81B | 37.54B |
| Cash & Short-Term Investments | 21.66B | 25.98B | 34.76B | 22.12B | 13.18B | 23.24B | 19.68B | 10.03B | 8.94B | 11.74B | 9.36B | 18.84B | 14.91B |
| Cash Only | 21.66B | 25.11B | 34.76B | 22.12B | 13.18B | 23.24B | 19.68B | 10.03B | 8.94B | 11.74B | 9.36B | 18.84B | 8.37B |
| Short-Term Investments | 0 | 877.53M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6.54B |
| Accounts Receivable | 17.09B | 29.4B | 23.13B | 16.42B | 20.23B | 19.88B | 14B | 11.14B | 9.66B | 9.33B | 9.59B | 12.12B | 9.58B |
| Days Sales Outstanding | 18.22 | 22.78 | 20.25 | 16.47 | 19.24 | 20.01 | 18.91 | 19.87 | 19.4 | 20.88 | 20.54 | 27.15 | 29.02 |
| Inventory | 38.89B | 43.63B | 41.02B | 32.99B | 37.85B | 33.95B | 22.7B | 17.35B | 14.5B | 12.45B | 12.28B | 13.98B | 9.84B |
| Days Inventory Outstanding | 36.15 | 38.77 | 42.27 | 37.14 | 42.78 | 42.15 | 36.83 | 36.69 | 34.08 | 32.6 | 30.07 | 36.37 | 35.29 |
| Other Current Assets | 19.74B | 2.38B | 7.11B | 7.08B | 8.12B | 6.85B | 4.15B | 3.41B | 3.8B | 2.58B | 2.69B | 4.86B | 3.03B |
| Total Non-Current Assets | 148.45B | 146.94B | 145.92B | 127.53B | 128.72B | 123.34B | 103.26B | 84.42B | 77.25B | 72.59B | 68.9B | 72.69B | 44.5B |
| Property, Plant & Equipment | 85.16B | 62.58B | 86.05B | 73.37B | 73.16B | 67.05B | 54.74B | 44.06B | 36.28B | 34.53B | 34.09B | 36.48B | 24.73B |
| Fixed Asset Turnover | 6.79x | 7.53x | 4.85x | 4.96x | 5.25x | 5.41x | 4.94x | 4.64x | 5.01x | 4.73x | 5.00x | 4.47x | 4.87x |
| Goodwill | 31.29B | 32.19B | 33.54B | 29.56B | 30.41B | 32.56B | 28.89B | 24.5B | 23.78B | 22.49B | 21.92B | 24.41B | 12.99B |
| Intangible Assets | 9.16B | 10.04B | 11.17B | 9.61B | 10.33B | 12B | 7.82B | 6.05B | 5.82B | 5.51B | 5.01B | 6.89B | 2.45B |
| Long-Term Investments | 53.71B | 26.13B | 237.24M | 274.02M | 294.84M | 243.19M | 171.1M | 93.63M | 84.97M | 64.01M | 362.63M | 354.13M | 295.35M |
| Other Non-Current Assets | 17.79B | 13B | 14.92B | 14.71B | 14.52B | 11.48B | 11.65B | 9.71B | 11.29B | 10B | 7.52B | 4.55B | 4.04B |
| Total Assets | 245.84B | 248.34B | 251.94B | 206.13B | 208.11B | 207.25B | 163.8B | 126.34B | 114.15B | 108.7B | 102.82B | 122.5B | 82.04B |
| Asset Turnover | 1.97x | 1.90x | 1.65x | 1.76x | 1.85x | 1.75x | 1.65x | 1.62x | 1.59x | 1.50x | 1.66x | 1.33x | 1.47x |
| Asset Growth % | -79.78% | -1.43% | 22.22% | -0.95% | 0.41% | 26.53% | 29.65% | 10.68% | 5.01% | 5.72% | -16.07% | 49.31% | - |
| Total Current Liabilities | 62.33B | 63.48B | 72.18B | 47.91B | 55.16B | 59.81B | 40.84B | 28.46B | 21.6B | 29.18B | 33.35B | 40.14B | 24.87B |
| Accounts Payable | 31.25B | 40.33B | 33.84B | 25.45B | 31.01B | 30.22B | 22.2B | 15.44B | 12.17B | 9.99B | 10.72B | 12.42B | 6.94B |
| Days Payables Outstanding | 30.08 | 35.83 | 34.88 | 28.66 | 35.05 | 37.51 | 36.01 | 32.65 | 28.58 | 26.17 | 26.24 | 32.31 | 24.89 |
| Short-Term Debt | 7.42B | 6.53B | 17.42B | 8.91B | 11.3B | 14.6B | 6.66B | 4.09B | 3.83B | 13.53B | 18.15B | 20.91B | 13.69B |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 7.26B | 6.45B | 9.25B | 4.87B | 4.09B | 5.66B | 4.33B | 3.37B | 1.57B | 2.17B | 1.46B | 3.55B | 2.13B |
| Current Ratio | 1.56x | 1.60x | 1.47x | 1.64x | 1.44x | 1.40x | 1.48x | 1.47x | 1.71x | 1.24x | 1.02x | 1.24x | 1.51x |
| Quick Ratio | 0.94x | 0.91x | 0.90x | 0.95x | 0.75x | 0.84x | 0.93x | 0.86x | 1.04x | 0.81x | 0.65x | 0.89x | 1.11x |
| Cash Conversion Cycle | 24.29 | 25.72 | 27.64 | 24.95 | 26.97 | 24.65 | 19.73 | 23.91 | 24.89 | 27.32 | 24.37 | 31.22 | 39.41 |
| Total Non-Current Liabilities | 135.59B | 132.5B | 129.38B | 111.22B | 103.14B | 99.65B | 79.42B | 65.4B | 64.6B | 53.38B | 45.95B | 52.74B | 31.53B |
| Long-Term Debt | 115.86B | 111.41B | 106.77B | 92.51B | 84.13B | 80.6B | 61.34B | 50.95B | 53.23B | 43.5B | 38.11B | 44.98B | 26.39B |
| Capital Lease Obligations | 24.23B | 7.77B | 8.66B | 7.21B | 7.2B | 6.78B | 4.81B | 3.77B | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 20.06B | 6.43B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 5.72B | 6.89B | 13.95B | 11.51B | 11.82B | 12.26B | 13.27B | 10.68B | 11.37B | 9.88B | 7.84B | 7.77B | 5.14B |
| Total Liabilities | 197.92B | 195.97B | 201.57B | 159.13B | 158.3B | 159.45B | 120.26B | 93.86B | 86.2B | 82.56B | 79.3B | 92.88B | 56.4B |
| Total Debt | 132.99B | 125.71B | 134.93B | 110.33B | 104.41B | 103.61B | 74.11B | 59.75B | 57.06B | 57.02B | 56.26B | 65.88B | 40.08B |
| Net Debt | 111.33B | 100.6B | 100.17B | 88.2B | 91.23B | 80.37B | 54.43B | 49.72B | 48.13B | 45.28B | 46.9B | 47.04B | 31.71B |
| Debt / Equity | 2.78x | 2.40x | 2.68x | 2.35x | 2.10x | 2.17x | 1.70x | 1.84x | 2.04x | 2.18x | 2.39x | 2.22x | 1.56x |
| Debt / EBITDA | 5.49x | 3.57x | 3.78x | 7.04x | 2.95x | 2.44x | 2.62x | 3.02x | 4.77x | 5.09x | 5.08x | 5.15x | 3.73x |
| Net Debt / EBITDA | 4.60x | 2.85x | 2.80x | 5.63x | 2.58x | 1.90x | 1.92x | 2.52x | 4.02x | 4.04x | 4.23x | 3.68x | 2.95x |
| Interest Coverage | 1.57x | 2.57x | 15.60x | 3.44x | 19.28x | 34.51x | 5.65x | 3.24x | 2.01x | 1.49x | 2.12x | 3.71x | 2.99x |
| Total Equity | 47.92B | 52.37B | 50.37B | 47B | 49.81B | 47.8B | 43.54B | 32.48B | 27.95B | 26.14B | 23.52B | 29.62B | 25.64B |
| Equity Growth % | -85.05% | 3.97% | 7.17% | -5.64% | 4.21% | 9.77% | 34.06% | 16.23% | 6.91% | 11.16% | -20.61% | 15.52% | - |
| Book Value per Share | 46.93 | 49.01 | 22.71 | 21.19 | 22.09 | 19.28 | 16.40 | 12.18 | 10.48 | 9.19 | 8.60 | 10.22 | 8.90 |
| Total Shareholders' Equity | 43.5B | 47.87B | 44.78B | 43.35B | 46.34B | 44.12B | 40.12B | 29.64B | 25.65B | 24.29B | 22.37B | 28.03B | 23.87B |
| Common Stock | 217.03M | 171.18M | 23.58B | 23.58B | 23.58B | 23.58B | 23.58B | 23.58B | 23.58B | 23.58B | 23.58B | 23.58B | 21.51B |
| Retained Earnings | 1.48B | 11.5B | 18.35B | 15.38B | 18.65B | 13.49B | 7.17B | 5.22B | 2.49B | 2.28B | 3.65B | 4.76B | 4.26B |
| Treasury Stock | 0 | -3.25B | 0 | 0 | 0 | -3.04B | -303.56M | -605.72M | -624.14M | 0 | -1.63B | -903.57M | -451.7M |
| Accumulated OCI | 1.28B | 39.44B | 2.65B | 4.18B | 3.9B | 9.88B | 9.47B | 1.23B | -10.39M | -1.78B | -3.44B | 387.79M | -1.66B |
| Minority Interest | 4.42B | 4.51B | 5.59B | 3.65B | 3.46B | 3.68B | 3.42B | 2.85B | 2.3B | 1.85B | 1.14B | 1.59B | 1.77B |
Quick answers to the most common questions about buying JBS stock.
As of 2025, Jbs N.V. (JBS) had total assets of $248.34B including $101.40B in current assets.
Jbs N.V. (JBS) carries total debt of $125.71B, offset by $25.98B in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Jbs N.V. (JBS) has total shareholders' equity (book value) of $47.87B ($49.01 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Jbs N.V. (JBS) reported a current ratio of 1.60x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.
Key Metrics
Top Statement Risk
Leverage amid thin margins
Metrics are mathematically derived from official filings.
Leverage Rising Faster Than Equity Base
According to reported balance sheet figures, JBS's total debt climbed from $118.2B in 2024Q2 to $133.0B in 2026Q3 while equity stayed near $43-48B, pushing the debt-to-equity ratio to 2.78 and suggesting the balance sheet is weakening over time.
The debt-to-equity ratio moved within a 2.30 to 2.78 band across the ten reported quarters, with the most recent reading near the top of that range. This pattern suggests leverage is building faster than retained value creation, which may limit the company's flexibility if margins stay compressed. Investors should monitor whether debt growth continues to outpace equity in the coming quarters.
Debt Burden Dominates Capital Structure
Based on JBS's reported figures, total liabilities of $197.9B against $43.5B of equity leave a leverage profile that appears heavy relative to the thin 2.3% operating margin reported in 2026Q3.
Total debt of roughly $133B represents the bulk of the liability base, and the 2.78 debt-to-equity ratio sits well above the 0.36 to 0.91 range of most protein and packaged food peers in the supplied set. Servicing this debt from earnings that have recently turned volatile may warrant further investigation into interest coverage and refinancing timing.
Current Ratio Stable but Cash Thin
As reported in financial statements, JBS's current ratio held between 1.47 and 1.62 across recent quarters, while cash of $21.7B in 2026Q3 provides a buffer that appears modest relative to its $133B debt stack.
A current ratio above 1.5 suggests near-term obligations are covered on paper, but cash has fluctuated sharply from $3.5B in 2026Q2 to $34.8B in 2024Q4. This volatility suggests liquidity depends heavily on timing of working capital and operating inflows rather than a stable cash reserve, which may leave limited cushion against an operating shock.
Goodwill and PP&E Anchor Asset Base
Based on reported figures, JBS carries $31.3B of goodwill and $85.2B of net PP&E in 2026Q3, indicating an asset base weighted toward acquired intangibles and physical processing capacity rather than liquid assets.
Goodwill accumulated through successive acquisitions represents a material share of total assets, which may expose the balance sheet to impairment if acquired operations underperform. The PP&E level suggests a capital-intensive processing footprint, though net PP&E has fluctuated materially between $16.0B and $86.0B across the reported quarters, warranting further investigation into how the reporting base is being measured.
Asset Figures Could Overstate Balance Sheet Strength
Based on reported figures, the headline asset base may appear more robust than it is, since goodwill and fair-value-sensitive biological assets could mask weakness if the underlying cash earnings deteriorate further.
Goodwill and intangibles tied to past M&A may not reflect recoverable value if margins remain near 2.3% operating, and impairment would reduce equity further from its already modest $43.5B level. The sharp swings in reported quarterly asset and PP&E figures also suggest the headline balance sheet should be read with caution, as short-sellers would likely emphasize the gap between book equity and the debt load.